Information de reference pour ce titreAccession Number: | 01445483-201907000-00010.
|
Author: | Stankovic, Iva MD 1,2; Quinn, Niall MD 3; Vignatelli, Luca MD 4; Antonini, Angelo MD 5; Berg, Daniela MD, PhD 6,7; Coon, Elizabeth MD 8; Cortelli, Pietro MD 4,9; Fanciulli, Alessandra MD, PhD 2; Ferreira, Joaquim J. MD, PhD 10; Freeman, Roy MD 11; Halliday, Glenda MD 12; Hoglinger, Gunter U. MD 13; Iodice, Valeria MD 14; Kaufmann, Horacio MD 15; Klockgether, Thomas MD 16; Kostic, Vladimir MD, PhD 1; Krismer, Florian MD, PhD 2; Lang, Anthony MD 17; Levin, Johannes MD 18; Low, Phillip MD 8; Mathias, Christopher MD 19,20,21; Meissner, Wassillios G. MD, PhD 22,23; Kaufmann, Lucy Norcliffe PhD 15; Palma, Jose-Alberto MD, PhD 15; Panicker, Jalesh N. MD, FRCP 3,24; Pellecchia, Maria Teresa MD, PhD 25; Sakakibara, Ryuji MD, PhD 26; Schmahmann, Jeremy MD 27; Scholz, Sonja W. MD, PhD 28,29; Singer, Wolfgang MD 8; Stamelou, Maria MD, PhD 30,31; Tolosa, Eduardo MD 32; Tsuji, Shoji MD,PhD 33,34; Seppi, Klaus MD, PhD 2; Poewe, Werner MD 2; Wenning, Gregor K. MD, PhD *,2; on behalf of the Movement Disorder Society Multiple System Atrophy Study Group
|
Institution: | (1) Neurology Clinic, Clinical Center of Serbia, School of Medicine University of Belgrade Belgrade Serbia (2) Department of Neurology Innsbruck Medical University Innsbruck Austria (3) University College London, Institute of Neurology Queen Square, London UK (4) Istituto di Ricovero e Cura a Carattere Scientifico, Istituto delle Scienze Neurologiche di Bologna Bologna Italy (5) Department of Neuroscience University of Padua Padua Italy (6) Department of Neurology Christian Albrecht University Kiel Germany (7) Hertie Institute for Clinical Brain Research Tubingen Tubingen Germany (8) Department of Neurology Mayo Clinic Rochester Minnesota USA (9) Dipartimento Scienze Biomediche e Neuromotorie, Alma Mater Studiorum University of Bologna Bologna Italy (10) Instituto de Medicina Molecular, Faculdade de Medicina Universidade de Lisboa Lisbon Portugal (11) Department of Neurology, Beth Israel Deaconess Medical Center Harvard Medical School Boston Massachusetts USA (12) Brain and Mind Centre, Sydney Medical School, University of Sydney, Camperdown, Australia; School of Medical Sciences University of New South Wales, Wales, Kensington, Australia; and Neuroscience Research Australia Randwick Australia (13) Department of Neurology Technische Universitat Munchen, and German Center for Neurodegenerative Diseases Munchen Germany (14) Autonomic Unit, National Hospital for Neurology and Neurosurgery, Queen Square/Division of Clinical Neurology, Institute of Neurology University College London London UK (15) Dysautonomia Center, Langone Medical Center New York University School of Medicine New York New York USA (16) Department of Neurology University of Bonn, and German Center for Neurodegenerative Diseases Bonn Germany (17) Edmond J. Safra Program in Parkinson's Disease, Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, University Health Network, Division of Neurology University of Toronto Toronto Ontario Canada (18) Department of Neurology Ludwig-Maximilians-Universitat Munchen, and German Center for Neurodegenerative Diseases Munchen Germany (19) Autonomic and Neurovascular Medicine Centre Hospital of St John & St Elizabeth London UK (20) Lindo Wing, Imperial College Healthcare National Health Service Trust St Mary's Hospital London UK (21) Queen Square Institute of Neurology University College London London UK (22) French Reference Center for MSA, Department of Neurology University Hospital Bordeaux Bordeaux France (23) Institute of Neurodegenerative Disorders University Bordeaux Bordeaux France (24) Department of Uro-Neurology The National Hospital for Neurology and Neurosurgery Queen Square, London UK (25) Center for Neurodegenerative Diseases, Department of Medicine and Surgery, Neuroscience Section University of Salerno Fisciano Italy (26) Neurology, Internal Medicine, Sakura Medical Center Toho University Sakura Japan (27) Department of Neurology, Massachusetts General Hospital Harvard Medical School Boston Massachusetts USA (28) Neurodegenerative Diseases Research Unit National Institute of Neurological Disorders and Stroke, National Institutes of Health Bethesda Maryland USA (29) Department of Neurology Johns Hopkins University Medical Center Baltimore Maryland USA (30) HYGEIA Hospital, Athens, Greece, Neurology Clinic University Marburg Marburg Germany (31) Department of Neurology University of Athens Athens Greece (32) Neurology Service, Hospital Clinic de Barcelona IDIBAPS, CIBERNED Barcelona Spain (33) Department of Molecular Neurology The University of Tokyo, Graduate School of Medicine Tokyo Japan (34) International University of Health and Welfare Chiba Japan
|
Title: | |
Source: | Movement Disorders. 34(7):975-984, July 2019.
|
References: | 1. Fanciulli A, Wenning G. Multiple-system atrophy. N Engl J Med 2015;372(3):249-263.
2. Wenning G, Ben-Shlomo Y, Hughes A, Daniel S, Lees A, Quinn N. What clinical features are most useful to distinguish definite multiple system atrophy from Parkinson's disease? J Neurol Neurosurg Psychiatry 2000;68(4):434-440.
3. Hughes AJ, Daniel SE, Ben-Shlomo Y, Lees AJ. The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain 2002;125(Pt 4):861-870.
4. Quinn N. Multiple system atrophy-the nature of the beast. J Neurol Neurosurg Psychiatry 1989;52(suppl):78-89.
5. Gilman S, Low PA, Quinn N, et al. Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci 1999;163(1):94-98.
6. Gilman S, Wenning G, Low P, et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology 2008;71(9):670-676.
7. Osaki Y, Ben-Shlomo Y, Lees A, Wenning G, Quinn N. A validation exercise on the new consensus criteria for multiple system atrophy. Mov Disord 2009;24(15):2272-2276.
8. Koga S, Aoki N, Uitti R, et al. When DLB, PD, and PSP masquerade as MSA. Neurology 2015;85(5):404-412.
9. Mestre T, Gupta A, Lang A. MRI signs of multiple system atrophy preceding the clinical diagnosis: the case for an imaging-supported probable MSA diagnostic category. J Neurol Neurosurg Psychiatry 2015;87(4):443-444.
10. Ozawa T, Paviour D, Quinn N, et al. The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations. Brain 2004;127(12):2657-2671.
11. Wenning G, Geser F, Krismer F, et al. The natural history of multiple system atrophy: a prospective European cohort study. Lancet Neurol 2013;12(3):264-274.
12. Low PA, Reich SG, Jankovic J, et al. Natural history of multiple system atrophy in the USA: a prospective cohort study. Lancet Neurol 2015;14(7):710-719.
13. Wenning GK, Scherfler C, Granata R, et al. Time course of symptomatic orthostatic hypotension and urinary incontinence in patients with postmortem confirmed parkinsonian syndromes: a clinicopathological study. J Neurol Neurosurg Psychiatry 1999;67:620-623.
14. Singer W, Berini SE, Sandroni P, et al. Pure autonomic failure: predictors of conversion to clinical CNS involvement. Neurology 2017;88(12):1129-1136.
15. Kaufmann H, Norcliffe-Kaufmann L, Palma JA, et al. Natural history of pure autonomic failure: a United States prospective cohort. Ann Neurol 2017;81(2):287-297.
16. Kollensperger M, Geser F, Seppi K, et al. Red flags for multiple system atrophy. Mov Disord 2008;23(8):1093-1099.
17. Batla A, Pablo-Fernandez E, Erro R, et al. Young-onset multiple system atrophy: clinical and pathological features. Mov Disord 2018;33(7):1099-1107.
18. Wenning G, Tison F, Ben-Shlomo Y, Daniel S, Quinn N. Multiple system atrophy: a review of 203 pathologically proven cases. Mov Disord 1997;12(2):133-147.
19. Petrovic IN, Ling H, Asi Y, Ahmed Z, et al. Multiple system atrophy-parkinsonism with slow progression and prolonged survival: a diagnostic catch. Mov Disord 2012;27(9):1186-1190.
20. Batla A, Stamelou M, Mensikova K, et al. Markedly asymmetric presentation in multiple system atrophy. Park Relat Disord 2013;19(10):901-905.
21. Aoki N, Boyer PJ, Lund C, et al. Atypical multiple system atrophy is a new subtype of frontotemporal lobar degeneration: frontotemporal lobar degeneration associated with [alpha]-synuclein. Acta Neuropathol 2015;130(1):93-105.
22. Koga S, Parks A, Uitti RJ, et al. Profile of cognitive impairment and underlying pathology in multiple system atrophy. Mov Disord 2017;32(3):405-413.
23. Stankovic I, Krismer F, Jesic A, et al. Cognitive impairment in multiple system atrophy: a position statement by the Neuropsychology Task Force of the MDS Multiple System Atrophy (MoDiMSA) Study Group. Mov Disord 2014;29(7):857-867.
24. Apostolova LG, Klement I, Bronstein Y, Vinters HV, Cummings JL. Multiple system atrophy presenting with language impairment. Neurology 2006;67(4):726-727.
25. Stamelou M, Quinn NP, Bhatia KP. "Atypical" atypical parkinsonism: new genetic conditions presenting with features of progressive supranuclear palsy, corticobasal degeneration, or multiple system atrophy-a diagnostic guide. Mov Disord 2013;28(9):1184-1199.
26. Postuma RB, Berg D, Stern M, et al. MDS clinical diagnostic criteria for Parkinson's disease. Mov Disord 2015;30(12):1591-1601.
27. The Multiple System Atrophy Research Collaboration . Mutations in COQ2 in familial and sporadic multiple system atrophy. N Engl J Med 2013;369(3):233-244.
28. Federoff M, Price TR, Sailer A, et al. Genome-wide estimate of the heritability of multiple system atrophy. Park Relat Disord 2016;22:35-41.
29. Massey L, Micallef C, Paviour D, et al. Conventional magnetic resonance imaging in confirmed progressive supranuclear palsy and multiple system atrophy. Mov Disord 2012;27(14):1754-1762.
30. Meyer P, Frings L, Rucker G, Hellwig S. 18F-FDG PET in parkinsonism: differential diagnosis and cognitive impairment in Parkinson's disease. J Nucl Med 2017;58(12):1888-1898.
31. Bajaj S, Krismer F, Palma J, et al. Diffusion-weighted MRI distinguishes Parkinson disease from the parkinsonian variant of multiple system atrophy: a systematic review and meta-analysis. PLoS One 2017;12(12):e0189897.
32. Scherfler C, Gobel G, Muller C, et al. Diagnostic potential of automated subcortical volume segmentation in atypical parkinsonism. Neurology 2016;86:1242-1249.
33. Orimo S, Suzuki M, Inaba A, Mizusawa H. 123I-MIBG myocardial scintigraphy for differentiating Parkinson's disease from other neurodegenerative parkinsonism: a systematic review and meta-analysis. Park Relat Disord 2012;18(5):494-500.
34. Pavy-Le Traon A, Piedvache A, Perez-Lloret S, et al. New insights into orthostatic hypotension in multiple system atrophy: a European multicentre cohort study. J Neurol Neurosurg Psychiatry 2016;87(5):554-561.
35. Gibbons C, Freeman R. Clinical implications of delayed orthostatic hypotension: a 10-year follow-up study. Neurology 2015;85(16):1362-1367.
36. Lipp A, Sandroni P, Ahlskog JE, et al. Prospective differentiation of multiple system atrophy from Parkinson's disease, with and without autonomic failure. Arch Neurol 2009;66(6):742-750.
37. Vogel ER, Sandroni P, Low PA. Blood pressure recovery from Valsalva maneuver in patients with autonomic failure. Neurology 2005;65(10):1533-1537.
38. Sakakibara R, Hattori T, Uchiyama T, Yamanishi T. Videourodynamic and sphincter motor unit potential analyses in Parkinson's disease and multiple system atrophy. J Neurol Neurosurg Psychiatry 2001;71(5):600-606.
39. Hahn K, Ebersbach G. Sonographic assessment of urinary retention in multiple system atrophy and idiopathic Parkinson's disease. Mov Disord 2005;20(11):1499-1502.
40. Nicoletti G, Lodi R, Condino F, et al. Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclear palsy. Brain 2006;129:2679-2687.
|
Language: | English.
|
Document Type: | Viewpoint.
|
Journal Subset: | Clinical Medicine.
|
ISSN: | 0885-3185
|
DOI Number: | https://dx.doi.org/10.1002/mds.2...- ouverture dans une nouvelle fenêtre
|
Annotation(s) | |
|
|